SCHEMBL20599732

SCHEMBL20599732

COC(=O)OC(=O)c1ccncc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
LMNA P02545 2/20 0.53
CYP2C9 P11712 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HSD17B10 Q99714 2/20 0.52
TP53 P04637 2/20 0.48
ALDH1A1 P00352 3/20 0.47
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
PTGS2 P35354 1/20 0.46
KDM4E B2RXH2 2/20 0.45
MAPT P10636 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
MPO P05164 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADORA3 P0DMS8 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27887982 0.85 CA1 (0.54) ALDH1A1MAPT
Methyl Isonicotinate SCHEMBL820082 0.83 CYP1A2 (0.60) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
Methyl Isonicotinate SCHEMBL180574 0.83 CYP1A2 (0.60) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
SCHEMBL647632 0.83 HSD17B10 (0.64) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
Methyl Isonicotinate SCHEMBL9213497 0.81 LMNA (0.58) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
Methyl Isonicotinate SCHEMBL29827431 0.81 LMNA (0.58) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
Methyl Isonicotinate SCHEMBL9217491 0.81 LMNA (0.58) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
SCHEMBL5015509 0.79 TSHR (0.68) LMNASMN1; SMN2HSD17B10TP53ALDH1A1
SCHEMBL6877560 0.79 HSD17B10 (0.55) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2
SCHEMBL19439269 0.78 HSD17B10 (0.50) CYP1A2CYP2C19LMNACYP2C9SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3645516-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS Janssen Pharmaceutica NV (BE) 2020-05-06 EP disclosed
WO-2019001420-A1 HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2019-01-03 WO disclosed